Animal and Human Ethical Conduct Policies
Any animal and human study should be authorized by the Institutional Review Board and Animal Care Committee of the institution where the study was conducted, respectively. Without prior clearance, the Journal of Drug Vigilance and Alternative Therapies will not consider any studies involving humans or animals. In the absence of a formal ethics committee, the authors should state whether the methods followed the Helsinki Declaration as updated in 2008.
Patients who take part in clinical trials should give their informed consent unless the Institutional Review Board waives this need. Patients' names, initials, hospital numbers, dates of birth, or other sensitive healthcare information should not be disclosed in order to safeguard human subjects. If animals are used in trials, the study should follow national or institutional animal care and use regulations.
Any study involving humans or animals that is submitted to Journal of Drug Vigilance and Alternative Therapies should include a description of whether the study was approved by the Institutional Review Board (with or without patient informed consent) and the animal care committee, respectively, of the institution where the study was conducted.
Informed consent and ethics committee approval are required for all human research submitted for publication in Journal of Drug Vigilance and Alternative Therapies. If the ethical committee authorized waiver of consent for retrospective research that do not compromise patient confidentiality or rights, this must be explicitly indicated in the cover letter and paper.